The high prevalence of osteoarthritis is emerging as a key driver of the acetylglucosamine market. The market is expected to register a favorable CAGR of 7.3% during the forecast period. Acetylglucosamine-induced dietary supplements help to increase joint lubrication. However, possible side effects such as constipation, heartburn, and nausea are affecting adoption rates of acetylglucosamine induced dietary supplements. As such, long-term safety of N-acetylglucosamine supplements is generally regarded as safe (GRAS) by the U.S. Food and Drug Administration (FDA).
Topics
